ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2026
Income Persistence and the Risk of Hepatocellular Carcinoma in Individuals with Type 2 Diabetes.
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundThis study aimed to examine the cumulative effect of income on hepatocellular carcinoma (HCC) risk in individuals with type 2 diabetes (T2D).
methodsA nationwide cohort of 1,516,897 adults with T2D and no history of cancer (2015-2016 baseline) from the Korean National Health Insurance Service was analyzed. Annual income was categorized into quartiles based on health insurance premiums, designating the highest quartile and lowest quartile as high- and low-income groups, respectively. Cumulative income status was assessed over 5 years, including the 4 years preceding and the baseline year. Incident HCC was identified via International Classification of Diseases, Tenth Revision (ICD-10) code.
resultsThe hazard ratio (HR) for 5-year consistent high-income status was 0.68 [95% confidence interval (CI), 0.65-0.72] compared with those never classified as the high-income group, whereas the HR for 5-year consistent low-income status was 1.34 (95% CI, 1.26-1.43) compared with those never classified as the low-income group. The HCC risk showed a significant duration-dependent trend in relation to cumulative exposure to low or high income, respectively (Ptrend < 0.0001). The association was stronger in those without chronic liver disease or major cancer risk factors and remained robust after adjusting for diabetes-related factors.
conclusionsProlonged low- or high-income status was independently associated with HCC risk among individuals with T2D, with a clear duration-dependent pattern. IMPACT: These findings emphasize how income stability independently affects the incidence risk of HCC in individuals with T2D.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.